Hot Stock List: Intel Corporation (NASDAQ:INTC), Medical Properties Trust Inc. (NYSE:MPW), Hercules Technology Growth Capital, Inc. (NYSE:HTGC), HEICO (NYSE:HEI), Conatus Pharmaceuticals (NASDAQ:CNAT)

On 31 July, Intel Corporation (NASDAQ:INTC) and Micron are starting production of a new, faster type of memory chip, which they say will change how computers access large amounts of data. On 05 August, Intel Corporation (NASDAQ:INTC) shares moved down -0.03% and was closed at $29.12. INTC EPS growth in last 5 year was 24.60%. Intel Corporation (NASDAQ:INTC) year to date (YTD) performance is -18.60%.

Medical Properties Trust Inc. (NYSE:MPW) announced financial and operating results for the second quarter ended June 30, 2015. Second quarter 2015 total revenues increased 30% to $99.8 million compared with $76.6 million for the second quarter of 2014.Medical Properties Trust Inc. (NYSE:MPW) shares decreased -6.09% in last trading session and ended the day at $12.65. MPW return on assets is 2.40%. Medical Properties Trust Inc. (NYSE:MPW) quarterly performance is -3.95%

Hercules Technology Growth Capital, Inc. (NYSE:HTGC) announced that it has scheduled its second quarter 2015 financial results conference call for Thursday, August 6, 2015, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. On 05 August, Hercules Technology Growth Capital, Inc. (NYSE:HTGC) shares decreased -0.71% and was closed at $11.20. HTGC EPS growth in last 5 year was 24.30%. Hercules Technology Growth Capital, Inc. (NYSE:HTGC) year to date (YTD) performance is -21.22%.

Zacks lowered shares of HEICO Corporation (NYSE:HEI) from a buy rating to a hold rating in a research report released on Tuesday morning. HEICO Corporation (NYSE:HEI) ended the last trading day at $53.92. Company weekly volatility is calculated as 2.01% and price to cash ratio as 156.06. HEICO Corporation (NYSE:HEI) showed a weekly performance of -0.50%.

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) announced financial results for the quarter and six months ended June 30, 2015. The net loss for the second quarter of 2015 was $6.1 million compared with $5.3 million for the second quarter of 2014. The net loss for the first six months of 2015 was $12.0 million compared with $10.5 million for the first six months of 2014.Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) ended the last trading day at $4.31. Company weekly volatility is calculated as 6.55% and price to cash ratio as 2.75. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) showed a weekly performance of -12.58%.

Leave a Reply

Your email address will not be published. Required fields are marked *